SylvesterRKLevittRSteenPD. Opioid-induced muscle activity: implications for managing chronic pain. Ann Pharmacother1995; 29: 1118–21.
2.
BreitbartWBrueraEChochinovHLynchM. A National Cancer Institute of Canada Workshop on symptom control and supportive care in patients with advanced cancer: methodological and administrative issues. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage1995; 10: 131–41.
3.
CoyleNBreitbartWWeaverSPortenoyR. Delirium as a contributing factor to “crescendo” pain: three case reports. J Pain Symptom Manage1994; 9: 44–7.
4.
FolsteinMFFettingJHLaboANiazUCapozzoliKD. Cognitive assessment of cancer patients. Cancer1984; 53 (suppl 10): 2250–7.
5.
TiseoPJThalerHTLapinJInturrisiCEPortenoyRKFoleyKM. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain1995; 61: 47–54.
6.
SjogrenPJonssonTJensenNHDrenckNEJensenTS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain1993; 55: 93–7.
7.
de StoutzNDBrueraESuarez-AlmazorM. Opioid rotation (OR) for toxicity reduction in terminal cancer patients. J Pain Symptom Manage1995; 10: 378–84.
8.
MacDonaldNDerLAllanSChampionP. Opioid hyperexcitability: the application of alternate opioid therapy. Pain1993; 53: 353–5.
9.
SjogrenPJensenNHJensenTS. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain1994; 59: 313–6.
10.
FainsingerRL. Case report: dehydration and narcotics: possible reversible causes of cognitive failure. Pain Manage Newsl1992; 5 (2 August): 7–8.
11.
FainsingerRLTapperMBrueraE. A perspective on the management of delirium in the terminally ill. J Palliat Care1993; 9 (3): 4–8.
12.
BrueraEWatanabeS. New developments in the assessment of pain in cancer patients. Support Care Cancer1994; 2: 312–8.
